Moriwaki Toshikazu
Assistant Professor
Faculty of Medicine
University of Tsukuba
Japan
Biography
Dr. Moriwaki Toshikazu is currently working as a Assistant Professor in the Department of Medicine, University of Tsukuba , japan. His research interests includes chemotherapy,esophageal cancer,gastric cancer,colorectal cancer,small bowel cancer,breathing tract cancer,pancreatic cancer. Dr. Moriwaki Toshikazu is serving as an editorial member and reviewer of several international reputed journals. Dr. Moriwaki Toshikazu is the member of many international affiliations. Dr. Moriwaki Toshikazu has successfully completed his Administrative responsibilities. Dr. Moriwaki Toshikazu has authored of many research articles/books related to chemotherapy,esophageal cancer,gastric cancer,colorectal cancer,small bowel cancer,breathing tract cancer,pancreatic cancer.
Research Interest
chemotherapy,esophageal cancer,gastric cancer,colorectal cancer,small bowel cancer,breathing tract cancer,pancreatic cancer
Publications
-
Horimatsu T, Nakayama N, Moriwaki T, Hirashima Y, Fujita M, Asayama M, Moriyama I, Nakashima K, Baba E, Kitamura H, Tamura T. A phase II study of 5-fluorouracil/L-leucovorin/oxaliplatin (mFOLFOX6) in Japanese patients with metastatic or unresectable small bowel adenocarcinoma. International Journal of Clinical Oncology. 2017 May 23:1-8.
-
Miura Y, Sukawa Y, Hironaka S, Mori M, Nishikawa K, Tokunaga S, Okuda H, Sakamoto T, Taku K, Nishikawa K, Moriwaki T. Five-weekly S-1 plus cisplatin therapy combined with trastuzumab therapy in HER2-positive gastric cancer: a phase II trial and biomarker study (WJOG7212G). Gastric Cancer. 2017 May 11:1-2.
-
Moriwaki T, Fukuoka S, Taniguchi H, Takashima A, Kumekawa Y, Kajiwara T, Yamazaki K, Esaki T, Makiyama C, Denda T, Satake H. Propensity Score Analysis of Regorafenib Versus Trifluridine/Tipiracil in Patients with Metastatic Colorectal Cancer Refractory to Standard Chemotherapy (REGOTAS): A Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study. The Oncologist. 2017 Sep 11:theoncologist-2017.
